New injection could shrink skin cancer before surgery
NCT ID NCT05858229
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental drug called RP1 that is injected directly into skin cancer tumors. The goal is to see if it can shrink or eliminate the cancer before surgery. Up to 12 adults with a type of skin cancer called cutaneous squamous cell carcinoma will take part. The study focuses on safety and how well the treatment works.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Rochester Dermatologic Surgery
Victor, New York, 14564, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Pre-Surgery immunotherapy prime the immune system to fight head and neck cancer?
- Glowing cancer cells: a new way to see tumors during surgery?
- Botox before the knife: could a Pre-Surgery injection lead to Better-Looking scars?
- Immunotherapy before surgery may cut skin cancer recurrence
- Mouth rinse could ease painful radiation side effects for head and neck cancer patients
- New skin patch could speed recovery after skin cancer removal